Balanced news tone
News Sentiment
BMY sentiment intelligence
Bristol-Myers Squibb Company news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
81/100 classification confidence.
directly relevant articles
high-authority source matches
+5.0% over one week, +14.7% over four weeks, trend inactive, and near fair-value range.
Bristol Myers Squibb (BMY) Expands AI Capabilities with Nvidia S
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Bristol Myers Squibb (BMY) Expands AI Capabilities with Nvidia S
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 21 Jul 2026 02:58
- Source
- GuruFocus
Lobbying Update: $3,160,000 of BRISTOL-MYERS SQUIBB COMPANY lobbying was just disclosed
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 21 Jul 2026 00:02
- Source
- Quiver Quantitative
Bristol Myers Squibb Co (NYSE:BMY): A High Yield Dividend Stock Backed by Strong Profitability
- Tone
- Positive 66/100
- Event
- Capital return
- Published
- 18 Jul 2026 12:20
- Source
- ChartMill
Is Bristol-Myers Squibb (BMY) Reasonable After Its 32% Run?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Jul 2026 10:41
- Source
- simplywall.st
ETFs Investing in Bristol-Myers Squibb Company Stocks
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Jul 2026 05:13
- Source
- TradingView
Lobbying Update: $60,000 of BRISTOL-MYERS SQUIBB lobbying was just disclosed
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jul 2026 23:22
- Source
- Quiver Quantitative
Why the Market Dipped But Bristol Myers Squibb (BMY) Gained Today
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jul 2026 21:45
- Source
- Market source
Bristol Myers Squibb Company (BMY) is Attracting Investor Attention: Here is What You Should Know
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jul 2026 13:00
- Source
- Market source
Bristol Myers Squibb (BMY) Stock Looks Cheap On Earnings But Mixed On Value
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 08 Jul 2026 07:00
- Source
- Market source
Bristol Myers Squibb (BMY) Stock Still Looks Undervalued Despite Mixed Risks
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 08 Jul 2026 07:00
- Source
- simplywall.st
Bristol-Myers Squibb: Cash Flow Machine, Outsized Growth Portfolio, And Inflation Beating Incomes
- Tone
- Positive 66/100
- Event
- Balance sheet
- Published
- 03 Jul 2026 07:00
- Source
- Seeking Alpha
Bristol Myers Squibb: Pain First, Payoff Later?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 03 Jul 2026 07:00
- Source
- Seeking Alpha
Bristol Myers Squibb Company (BMY) Is a Trending Stock: Facts to Know Before Betting on It
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Jul 2026 07:00
- Source
- Market source
3 Reasons to Buy Bristol Myers Squibb Stock
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 22 Jun 2026 07:00
- Source
- The Motley Fool
Bristol Myers Squibb (BMY) Stock Could Be 12.2% Undervalued on Pipeline and Margin Hopes
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 17 Jun 2026 07:00
- Source
- Market source
Bristol Myers Squibb (BMY) Stock Moves -1.14%: What You Should Know
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Jun 2026 07:00
- Source
- Market source
How Safe is Bristol Myers Squibb's Dividend? Here's My Honest Take.
- Tone
- Neutral 50/100
- Event
- Capital return
- Published
- 13 Jun 2026 07:00
- Source
- Market source
Bristol Myers Squibb vs Pfizer Dividend Stock Comparison 2026 - News and Statistics
- Tone
- Neutral 50/100
- Event
- Capital return
- Published
- 04 Jun 2026 07:00
- Source
- IndexBox
Is Bristol-Myers Squibb Stock Underperforming the Dow?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jun 2026 07:00
- Source
- Barchart.com
Assessing Bristol Myers Squibb (BMY) Valuation As Shares Track Mixed Returns And Earnings Outlook
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 02 Jun 2026 07:00
- Source
- Market source
Bristol-Myers Squibb Stock Rises on Anthropic AI Deal. Why This Could Actually Be a Key Upside Catalyst.
- Tone
- Positive 66/100
- Event
- Deals and strategy
- Published
- 22 May 2026 07:00
- Source
- Barchart.com
Tigerlily Foundation Collaborates with Bristol Myers Squibb to Advance Clinical Trial Access and Equity
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 May 2026 07:00
- Source
- PR Newswire
Do Wall Street Analysts Like Bristol-Myers Squibb Stock?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 Apr 2026 07:00
- Source
- Barchart.com
Bristol Myers Squibb Stock Gains 20% Amid 2026 Revenue Outlook
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 27 Apr 2026 07:00
- Source
- IndexBox
UBS raises Bristol-Myers Squibb stock price target on pipeline outlook
- Tone
- Positive 66/100
- Event
- Guidance
- Published
- 06 Mar 2026 08:00
- Source
- Investing.com
Is Bristol-Myers Squibb Stock Underperforming the Nasdaq?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 27 Feb 2026 08:00
- Source
- Barchart.com